Q4 FY2026 Quarterly Result Highlights of Apollo Hospitals, UNO Minda, Carysil, Dynamic Cables, Samvardhana Motherson & Max Healthcare Instutite

UNO Minda Q4 FY2026 Result: PAT jumps 22% & Revenue up 18% YoY

• UNO Minda reported a strong Q4 FY2026 performance, with consolidated revenue rising 18% year-over-year to ₹5,336 crore and net profit increasing 22% to ₹326 crore. The stellar quarter was driven by higher volumes and strong demand for value-added automotive products across both core and emerging businesses.
• Financial Highlights (Q4 FY2026)
• Revenue from Operations: ₹5,336 crore (Up 17.8% YoY).
• EBITDA: ₹603 crore (Up 14.5% YoY).
• EBITDA Margin: 11.3% (slightly lower than 11.6% in Q4 FY25).
• Net Profit (PAT): ₹326 crore (Up 21.6% YoY).
• Earnings Per Share (EPS): ₹5.64 per share.
• Full Year Highlights (FY2026)
• Normalised Revenue: ₹19,589 crore (Up 17% YoY).
• Normalised PAT: ₹1,166 crore (Up 24% YoY).
• Key Strategic & Corporate Updates
• Dividend: The board recommended a final dividend of ₹1.75 per share, bringing the total dividend for FY26 to ₹2.65 per share.
• Fundraise: The board approved a fundraise plan of up to ₹2,500 crore via QIP or other modes to fuel future expansion.
• New Plant: Approved the establishment of a second EV powertrain manufacturing plant at a cost of ₹550 crore
• Stock Reaction: Neutral.

Apollo Hospitals strong Q4 FY26 Result: PAT surging 36% YoY & Revenue up 18%

• Apollo Hospitals reported a strong fourth-quarter performance for FY26, with consolidated net profit surging 36% year-on-year to ₹529 crore. Revenue increased 18% YoY to ₹6,605 crore, while EBITDA grew by 31% to ₹1,011 crore. The company also recommended a final dividend of ₹10 per equity share.
• Financial Performance Overview
• Revenue ₹6,605 crore, up 18%
• EBITDA ₹1,011 crore, up 31%
• Net Profit (PAT) ₹529 crore, up 36%
• EBITDA Margin 15.3% Expanded ~150 bps
• Key Highlights
• Dividend: The board of directors declared a final dividend of ₹10 per share for the fiscal year, with the record date set for August 14, 2026.
• Operational Milestones: The robust quarterly performance was supported by higher hospital bed occupancy rates, sustained operating momentum, and a strong contribution from Apollo Health Co.
• Other Corporate Actions: The board reappointed Dr. Prathap C. Reddy as Executive Chairman for a two-year term effective June 25, 2026
• Stock Reaction: Positive.
• 22 May 2026 ICICI Direct Target 9660.00
• 22 May 2026 Prabhudas Lilladhar Target 9350.00

Carysil robust Q4 FY2026 result: PAT up 45% & Revenue up 14% YoY

• Carysil reported robust consolidated financial results for Q4 FY26, with net profit surging 45.86% year-over-year to ₹27.10 crore and operational revenue jumping 14.47% to ₹233.72 crore. Growth was primarily driven by strong volume demand in the quartz kitchen sink segment and improved operational efficiencies.
• Carysil’s consolidated Q4 FY26 EBITDA stood at ₹45.1 crore, marking a 29.2% increase from ₹34.9 crore in the same quarter last year. The EBITDA margin expanded to 19.3% during the quarter, up from 17.1% in Q4 FY25.

Q4 FY26 Financial Highlights

• Net Profit: ₹27.10 crore (up 45.86% from ₹18.58 crore in Q4 FY25)
• Revenue: ₹233.72 crore (up 14.47% from ₹204.18 crore in Q4 FY25)
• Operating Margin (OPM): Expanded to 19.27% (up from 17.11% YoY)
• Dividend: The board recommended a final dividend of ₹3 per share (150% of face value) for the financial year ended March 31, 2026.

Full Year (FY26) Financial Highlights

• Full Year Net Profit: ₹98.19 crore (a 54.05% increase compared to ₹63.74 crore in FY25)
• Full Year Revenue: ₹923.95 crore (a 13.29% increase compared to ₹815.57 crore in FY25)

Strategic & Operational Updates

• Capacity Expansion: Carysil is expanding its quartz kitchen sink capacity from 1.0 million to 1.25 million units per annum. The ~₹50 crore expansion is backed by US retail chain partnerships and is slated to be completed by FY27 to support incremental volume growth.
• Utilization: Q4 FY26 capacity utilization remained steady at approximately 78%, highlighting strong, demand-led operational leverage.

Stock Reaction: Positive.

25 May 2026 Keynote Capitals Ltd Target 1327.00

Dynamic Cables Q4 FY2026 Result: PAT up 2.6% & revenue up 7% YoY, margin declined

• Dynamic Cables reported its Q4 FY26 results with a net profit of ₹24.17 crore and a record quarterly revenue of ₹355.46 crore. While net profit rose 2.6% year-on-year and revenue grew 7.33%, the company’s operating margin saw a sequential decline to 10.56%.
• Q4 FY26 Key Financial Highlights
• Revenue: ₹355.46 crore, marking an 18.97% sequential increase from Q3 FY26 and a 7.33% increase compared to ₹331.18 crore in Q4 FY25.
• Net Profit: ₹24.17 crore, up 2.6% YoY from ₹23.56 crore.
• Operating Margin (OPM): 10.56%, experiencing a compression of 90 bps compared to the previous quarter.
• Full-Year FY26 Performance: 
• Annual operating revenue stood at ₹1,197.8 crore (up 17% YoY) with a Profit After Tax (PAT) of ₹84.4 crore (up 30% YoY).
• Order Book: Strong pipeline of approximately ₹808 crore.
• Dynamic Cables reported a standalone EBITDA of ₹38.51 crore for Q4 FY26, representing an 8.11% increase from ₹35.62 crore in Q4 FY25. Operating margins for the quarter stood at approximately 10.56%.
• Q4 FY26 Financial Highlights
  • Revenue: ₹355.46 crore, up 7.33% YoY.
  • EBITDA: ₹38.51 crore, up 8.11% YoY.
  • Net Profit (PAT): ₹24.17 crore, up 2.58% YoY.
  • Order Book: Reached a highest-ever level of approximately ₹808 crore as of March 31, 2026
• Market Response
• Despite the record quarterly revenues and strong full-year profitability, the stock experienced selling pressure following the announcement, driven by the sequential dip in profit margins and profit-booking.

Stock Reaction: Negative.

Samvardhana Motherson Q4 FY2026: PAT up 42.5% & Revenue up 17% YoY

• Samvardhana Motherson reported a strong quarter, with consolidated net profit jumping 42.5% YoY to ₹1,497 crore and revenue rising 17% YoY to ₹34,309 crore.
• The board also recommended a final dividend of ₹0.25 per equity share.
• Key financial and operational highlights for Q4 FY26:
• Revenue from Operations: ₹34,309.31 crore, marking a 9.2% sequential growth (QoQ) and 17% YoY growth.
• Profit After Tax (PAT): ₹1,497 crore, a 42.5% jump from ₹1,051 crore in Q4 FY25.
• EBITDA: Reported at ₹3,805 crore.
• Dividend: Final dividend of ₹0.25 per share, bringing the total FY26 dividend to ₹0.60 per share.
• Segment Contributions
• Modules and polymer products: ₹16,737 crore
• Wiring harness: ₹10,236 croreVision systems: ₹5,533 crore
• Emerging businesses & Integrated assemblies: ₹8,027 crore
• Operational Highlights
• Record Execution: The company achieved its highest-ever quarterly and annual revenue (₹1,26,104 crore) for FY26.
• Growth Drivers: Emerging markets drove passenger vehicle (PV) volume growth, supported by steady commercial vehicle performance in developed markets.
• Order Book: The company commands a massive automotive booked business pipeline worth over USD 83.9 billion
• Stock Reaction: Positive.

Max Healthcare Q4 FY2026 results: Revenue up 10% & EBITDA up 8% YoY

• Max Healthcare Institute reported its Q4 FY2026 results on May 21, 2026, posting a 10% YoY increase in network gross revenue to ₹2,664 crore and a network Profit After Tax (PAT) of ₹387 crore. The board also approved an investment of ₹1,400 crore for a new 712-bed hospital in Lucknow.
• Key Financial Highlights
• Network Gross Revenue: ₹2,664 crore, up 10% YoY driven by higher occupied bed days.
• Network Operating EBITDA: ₹682 crore, reflecting an 8% YoY growth.
• EBITDA Margin: Softened to 26.8% (compared to 27.2% in Q4 FY25), largely due to upfront investments in clinical talent and capacity expansions.
• PAT (Profit After Tax): Stood at ₹342.22 crore (up 7.3% YoY) on a standalone/consolidated basis, with network-level PAT at ₹387 crore.
• Full-Year FY26 Performance
• Gross revenue of ₹10,538 crore, up 16% YoY
• Operating EBITDA of ₹2,638 crore, up 14% YoY
• Operating margin of 26.2%
• Dividend Announcement
• The Board of Directors recommended a final dividend of ₹2 per equity share for the financial year 2025-2026.
• Operational & Expansion Updates
• Capacity Additions: The company successfully commissioned brownfield expansions adding approximately 20% to its capacity across Mohali, Mumbai, and Delhi over the last six months.
• New Projects: Construction was approved for a 712-bed greenfield hospital at Shaheed Path, Lucknow.
• International Revenue: Grew 12% YoY to ₹227 crore, contributing around 9% of total hospital revenue.
• Debt Position: Net debt reduced significantly to ₹1,908 crore as of March 2026, down from ₹2,166 crore in December 2025